Semaglutide (Semi-Recombinant)- Hybio Pharmaceutical Co. Ltd.

Home>Product>Semaglutide (Semi-Recombinant)

Semaglutide (Semi-Recombinant)

Purchase Qty: 1 100 1000
Unit: g(s) g(s) g(s)
Fob Unit Price: US $250 US $200 US $150
Payment Terms:T/T

Favorite

Hybio Pharmaceutical Co. Ltd.

Business Type:Manufacturer

Country/Region:China

Ddu Verified

HOT Rank

6/10

Product Information

Active Ingredients:Semaglutide (Semi-Recombinant)
Chemical Formula:C₁₈₇H₂₁N₄₅O₅₉
Molecular Weight:4113.6 g/mol
Assay:HPLC-UV / LC-MS
Pharmacopeia:CP
Package Type:Aluminum foil bag + desiccant + carton OR Lyophilized vial
Shelf Life:18 months
Storage:-20℃
Place of Origin:China

Description

Semaglutide (Semi-Recombinant) is a high-purity Active Pharmaceutical Ingredient (API) designed for the formulation of advanced therapeutic agents targeting Type 2 Diabetes Mellitus (T2DM) and chronic weight management. As a long-acting glucagon-like peptide-1 (GLP-1) receptor agonist, Semaglutide mimics the physiological effects of the endogenous human GLP-1 hormone. The "Semi-Recombinant" designation indicates a sophisticated manufacturing process that combines recombinant DNA technology with precise chemical synthesis. This hybrid approach ensures the production of a peptide sequence that is structurally identical to the clinical reference standard while optimizing yield, scalability, and cost-effectiveness for global pharmaceutical supply chains.